Overview
Mahalia Desruisseaux is an Infectious Disease provider in New Haven, Connecticut. Dr. Desruisseaux is rated as an Elite provider by MediFind in the treatment of Primary Amebic Meningoencephalitis. Her top areas of expertise are Primary Amebic Meningoencephalitis, Malaria, Chagas Disease, and Severe Acute Respiratory Syndrome (SARS).
Her clinical research consists of co-authoring 19 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 6 articles in the study of Primary Amebic Meningoencephalitis.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
20 York St, New Haven, CT 06510
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Montefiore Weiler Hospital
Our primary research interest is in the biology, pathogenesis and immunology of Plasmodium falciparum. Patients infected with this parasite can be completely asymptomatic or develop severe disease resulting in death. The goal of our research has been to define the molecular mechanisms that underlie this variation in disease outcomes in P. falciparum. Toward this goal, we have developed a new pathogenesis model through the analysis of in vivo parasite biology and associated host factors using a whole genome and metabolomic approach. We have identified novel parasite biology when it resides in the human host and idnetified a putative mediator of coma in cerebral malaria. We also are studying adjunctive therapy to improve outcomes in severe malaria using the animal model. We carry out field based translational studies in cohorts infected with malaria in Africa and test hypothesis in the animal model of malaria. The long term goal is to identify parasite and host processes involved in disease to serve as targets for vaccine or chemotherapeutic development. Dr. Daily is rated as a Distinguished provider by MediFind in the treatment of Primary Amebic Meningoencephalitis. Her top areas of expertise are Primary Amebic Meningoencephalitis, Malaria, Togaviridae Disease, Severe Acute Respiratory Syndrome (SARS), and Leg or Foot Amputation.
Theresa Madaline is an Infectious Disease provider in New York, New York. Dr. Madaline is rated as an Experienced provider by MediFind in the treatment of Primary Amebic Meningoencephalitis. Her top areas of expertise are Primary Amebic Meningoencephalitis, Osteomyelitis, Osteomyelitis in Children, and Malaria.
Nuvance Health Medical Practice Ct Inc
Julie Varughese is an Infectious Disease specialist and a Pediatrics provider in Norwalk, Connecticut. Dr. Varughese is rated as an Experienced provider by MediFind in the treatment of Primary Amebic Meningoencephalitis. Her top area of expertise is Primary Amebic Meningoencephalitis.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Primary Amebic MeningoencephalitisDr. Desruisseaux isElite. Learn about Primary Amebic Meningoencephalitis.
- Advanced
- MalariaDr. Desruisseaux isAdvanced. Learn about Malaria.
- Experienced
- Chagas DiseaseDr. Desruisseaux isExperienced. Learn about Chagas Disease.
- COVID-19Dr. Desruisseaux isExperienced. Learn about COVID-19.
- SepsisDr. Desruisseaux isExperienced. Learn about Sepsis.
- Severe Acute Respiratory Syndrome (SARS)Dr. Desruisseaux isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).
